Cefoperazone (T-1551) 投与例の臨床的研究

DOI Web Site

書誌事項

タイトル別名
  • THE CLINICAL STUDIES OF CEFOPERAZONE (T-1551) IN OTO-RHINO-LARYNGOLOGICAL FIELD
  • Cefoperazone T 1551 トウヨレイ ノ リンショウテキ ケンキ
  • 耳鼻咽喉科領域の感染症

この論文をさがす

抄録

Cefoperazone (CPZ, T-1551) was tested clinically in 15 cases (7 with sinal, tonsillar or laryngeal acute infections, 6 with Pseudomonas aeruginosa infections following total resection of sinal, laryngeal or glossal cancers, one with reticulosarcoma of nose infected by Staphylococcus aureus and one with rhinitis gangrenosa infected by Klebsiella) by the intravenous injection or intravenous drip infusion of 0.5-4 g of CPZ daily for a short or long duration.<BR>As a result, the responses were “excellent” in 4 cases, “good” in 9 and “poor” in 2. It was concluded that the effective results (good to excellent) was obtained in a large number as 13 out of 15 (86%) by the intravenous administration of CPZ. No side effect was found in all 15 cases.

収録刊行物

詳細情報 詳細情報について

問題の指摘

ページトップへ